In an animal model of the disease, GB Sciences' formulations were able to reduce Parkinson's disease-like behavioral symptoms 'back to baseline' with negligible side effects. LAS VEGAS, Dec. 20, 2019 /PRNewswire/ -- GB Sciences, Inc Continue reading →

Dysarthria is a collective term for a group of speech disorders that occur as a result of muscle weakness. People with dysarthria have neurological damage that weakens the muscles necessary for speech Continue reading →

We are always looking for innovative new treatments,from immunotherapy to gene therapy to novel antibiotics. But what if we had innovative new treatments inside our own body, namely our gut bacteria Continue reading →

Touted as the largestamyotrophic lateral sclerosis (ALS) investigative effort to date, the Answer ALS research program has finished an initial technology infrastructure stage and is ready to embark on its goal of finding more effective ALS treatmentsand, ideally, a cure. A consortium of nearly two dozen medical research centers, technology companies, and 1,000 ALS patients, the program seeks to build the most comprehensive clinical, genetic, molecular, and biochemical assessment ever done into ALS. Results will be shared via secure links with the global research community. Continue reading →

Insight into Competitive Landscape : Market players need to have a complete picture of the competitive landscape of the Parkinsons Disease Treatment market as it forms an essential tool for them to plan their future strategies accordingly. Continue reading →

Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors Continue reading →

Sleeping difficulty refers to difficulty falling asleep, difficulty staying asleep, or waking up too early. Continue reading →